RT Journal Article
SR Electronic
T1 Using the ROX Index to Predict Treatment Outcome for High-Flow Nasal Cannula and/or Noninvasive Ventilation in Patients With COPD Exacerbations
JF Respiratory Care
FD American Association for Respiratory Care
SP respcare.11544
DO 10.4187/respcare.11544
A1 Schaeffer, Brett Z
A1 Fazio, Sarina A
A1 Stocking, Jacqueline C
A1 Adams, Jason Y
A1 Liu, Anna
A1 Black, Hugh B
A1 Harper, Richart W
A1 Cortes-Puch, Irene
A1 Albertson, Timothy E
A1 Kuhn, Brooks T
YR 2024
UL http://rc.rcjournal.com/content/early/2024/04/23/respcare.11544.abstract
AB BACKGROUND: The ratio of oxygen saturation index (ROX index; or SpO2/FIO2/breathing frequency) has been shown to predict risk of intubation after high-flow nasal cannula (HFNC) support among adults with acute hypoxemic respiratory failure primarily due to pneumonia. However, its predictive value for other subtypes of respiratory failure is unknown. This study investigated whether the ROX index predicts liberation from HFNC or noninvasive ventilation (NIV), intubation with mechanical ventilation, or death in adults admitted for respiratory failure due to an exacerbation of COPD.METHODS: We performed a retrospective study of 260 adults hospitalized with a COPD exacerbation and treated with HFNC and/or NIV (continuous or bi-level). ROX index scores were collected at treatment initiation and predefined time intervals throughout HFNC and/or NIV treatment or until the subject was intubated or died. A ROX index score of ≥ 4.88 was applied to the cohort to determine if the same score would perform similarly in this different cohort. Accuracy of the ROX index was determined by calculating the area under the receiver operator curve.RESULTS: A total of 47 subjects (18%) required invasive mechanical ventilation or died while on HFNC/NIV. The ROX index at treatment initiation, 1 h, and 6 h demonstrated the best prediction accuracy for avoidance of invasive mechanical ventilation or death (area under the receiver operator curve 0.73 [95% CI 0.66–0.80], 0.72 [95% CI 0.65–0.79], and 0.72 [95% CI 0.63–0.82], respectively). The optimal cutoff value for sensitivity (Sn) and specificity (Sp) was a ROX index score > 6.88 (sensitivity 62%, specificity 57%).CONCLUSIONS: The ROX index applied to adults with COPD exacerbations treated with HFNC and/or NIV required higher scores to achieve similar prediction of low risk of treatment failure when compared to subjects with hypoxemic respiratory failure/pneumonia. ROX scores < 4.88 did not accurately predict intubation or death.